Processing…
Success! You're on the list.
NEWSLETTER

Processing…
Success! You're on the list.

Bioniq hits $82M valuation with Cristiano Ronaldo’s backing in its AI-driven supplements

Bioniq funding
Picture credits: Bioniq

London-based Bioniq, which provides personalised nutritional support based on blood biomarker data, has announced that the global soccer legend Cristiano Ronaldo has financed an undisclosed investment amount in the company. With this investment, the total valuation of the company has reached $82 million. This was followed by the $15 million Series B round led by European VCs – Principal Investors HV Capital and Unbound. 

Ronaldo’s investment comes at a time when the company is accelerating global expansion with a focus on the US, Europe, and the Middle East. His strategic involvement in product development, shaped by his unique performance needs and firsthand experience throughout various stages of his career, brings invaluable insight to Bioniq. As an athlete who has excelled across age categories, his contributions will be instrumental to Bioniq’s approach to personalised health solutions. His support will further propel the company’s mission to deliver precision nutritional supplementation to millions, empowering them to achieve optimal health outcomes.

Ronaldo’s stake in the company underscores his commitment to optimising health and performance, both on and off the field. Also, it highlights vitamins, minerals, and supplements as a key emerging category for high-performance athletes and consumers alike. Ronaldo will also participate in future brand and product innovation.

“Backing Bioniq goes beyond just an investment opportunity for me—it’s about aligning with a shared vision for health, performance, and longevity,” said Cristiano Ronaldo. “I have been using their products myself for almost three years. With their personalised health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer.”

Personalised healthcare solutions 

Founded by Vadim Fedotov and Dr. Konstantin Karuzin in 2019 in London, Bioniq is a healthtech startup that provides personalised supplements based on blood test data. The company uses an AI-powered algorithm to assess an individual’s needs and creates a unique formula with vitamins, minerals, and other nutrients to address deficiencies. 

The AI-powered patent-pending Bioniq algorithm assesses an individual’s height, weight, age, lifestyle, and health goals to precisely identify micronutrient imbalances and deliver nutritional insights, daily nutrient support, and 1:1 nutrition consultations and educational resources. Sold in over 70 countries and with its total user base growing more than 5x in 2024, Bioniq’s approach is backed by renowned scientists and a patent-pending algorithm.

High-quality supplements 

All of Bioniq’s supplements are Swiss-made, pharmaceutical-grade, and utilise precise micro-dosing to address bio-individual needs and deficiencies. Each formula is created specifically for an individual user and features a unique mix of up to 120 antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fibre. Rather than traditional pills and capsules, the product is delivered in patented prebiotic guar granules, which are designed to mimic the way the body digests food, minimising nutrient competition and maximising bioavailability.

Its ability to provide quantifiable before-and-after snapshots of users’ nutrient needs and optimisation progress has been an invaluable asset in its partnerships with many leading health and sports institutions such as Lanserhof and UFC. It has also become the product of choice for many other of the world’s top athletes from Soccer World Cup Champions, and NBA All-Stars to Iron Man winners.

“Cristiano Ronaldo is the perfect partner and shareholder. As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq,” said Vadim Fedotov, Co-Founder and CEO of Bioniq. “We are thrilled that the world’s leading athlete and advocate of a healthy lifestyle has made Bioniq part of his journey since 2022. His personal experience with our products reinforces his belief in what we’re building. Cristiano’s decision to invest, highlights his confidence in our team’s vision and his commitment to helping us build the leading company in personalised health.”

Bioniq’s products 

Bioniq offers two options: Bioniq Go, which uses a quiz to determine your needs, and Bioniq Pro, which requires a blood test for a more precise analysis. These supplements are made with high-quality ingredients and designed for optimal absorption by the body. Bioniq’s Go uses 3 million proprietary biochemical data points to create unique formulas for each user.

What do we think about Bioniq?

In addition to offering personalised supplements based on blood test data, Bioniq supplements are also made with high-quality ingredients and designed for optimal absorption by the body. With Cristiano Ronaldo’s recent investment, Bioniq is poised for further growth and innovation in the personalised health market.

Related Posts
Total
0
Share

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you